Skip to main navigation
Fulcrum Therapeutics logo
Menu Button

Main Menu

  • About
  • Our Approach
  • Pipeline
    • Publications
  • Therapeutic Focus
    • FSHD
    • SCD
    • Beta-thalassemia
  • Careers
    • Current Openings
    • Faces of Fulcrum
  • Investor Relations
    • News Releases
    • Events and Presentations
    • Stock Information
    • SEC Filings
    • Corporate Governance
    • Investor FAQs
  • Contact

Corporate Governance

Corporate Governance

Committee Charters
Nominating and Corporate Governance Committee Charter
Audit Committee Charter
Science and Technology Committee Charter
Compensation Committee Charter
Governance Documents
Code of Business Conduct & Ethics
Corporate Governance Guidelines

Committee Composition

Audit Committee Compensation Committee Nominating and Corporate Governance Committee Science and Technology Committee
James J. Collins, Ph.D. Nominating and Corporate Governance Committee Science and Technology Committee
Katina Dorton Audit Committee Compensation Committee
Alan Ezekowitz, MBChB, D.Phil Compensation Committee Science and Technology Committee
James Geraghty Audit Committee Nominating and Corporate Governance Committee
Kate Haviland Audit Committee Compensation Committee
Mark Levin Nominating and Corporate Governance Committee Science and Technology Committee
= Chairperson = Member = Chairman of the Board

Investor Tools

Print
Email Page
Email Alerts
IR Contact
Fulcrum Therapeutics logo
  • Privacy Policy
  • EU Privacy Policy
  • Terms of Use
  • Twitter
  • LinkedIn
  • Instagram

Main Menu

  • About
  • Our Approach
  • Pipeline
    • Publications
  • Therapeutic Focus
    • FSHD
    • SCD
    • Beta-thalassemia
  • Careers
    • Current Openings
    • Faces of Fulcrum
  • Investor Relations
    • News Releases
    • Events and Presentations
    • Stock Information
    • SEC Filings
    • Corporate Governance
    • Investor FAQs
  • Contact